Patents by Inventor Axel Kowald

Axel Kowald has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170009300
    Abstract: The present invention relates to new marker sequences for rheumatoid arthritis and the diagnostic use thereof together with a method for screening of potential active substances for rheumatoid arthritis by means of these marker sequences. Furthermore, the invention relates to a diagnostic device containing such marker sequences for rheumatoid arthritis, in particular a protein biochip and the use thereof.
    Type: Application
    Filed: September 23, 2016
    Publication date: January 12, 2017
    Inventors: Jens Beator, Angelika Lüking, Axel Kowald, Helmut E. Meyer
  • Publication number: 20150197820
    Abstract: The present invention relates to novel marker sequences for inflammatory prostate diseases, prostate carcinoma and the diagnostic use thereof together with a method for screening of potential active substances for inflammatory prostate diseases, prostate carcinoma by means of these marker sequences. Furthermore, the invention relates to a diagnostic device containing such marker sequences for inflammatory prostate diseases, prostate carcinoma, in particular a protein biochip and the use thereof.
    Type: Application
    Filed: March 30, 2015
    Publication date: July 16, 2015
    Inventors: Helmut E. MEYER, Angelika Lueking, Jens Beator, Axel Kowald, Georg Bartsch, Helmut Klocker
  • Publication number: 20150177247
    Abstract: The present invention relates to a method for identifying marker sequences for gynaecological malignoma, the marker sequences identified with the aid of this method and diagnostic use thereof, diagnostic devices containing marker sequences for gynaecological malignoma, in particular an arrangement and a protein array, and use thereof. The invention also relates to method for the screening of potential active agents for the treatment and prevention of gynaecological malignoma by means of these marker sequences.
    Type: Application
    Filed: February 27, 2015
    Publication date: June 25, 2015
    Inventors: ANGELIKA LÜKING, Axel Kowald, Annabel Höpner, Peter Schulz-Knappe, Christian Scheer, Heidelinde Fiegl, Günter Daxenbichler
  • Publication number: 20150087548
    Abstract: The present invention relates to new marker sequences for rheumatoid arthritis and the diagnostic use thereof together with a method for screening of potential active substances for rheumatoid arthritis by means of these marker sequences. Furthermore, the invention relates to a diagnostic device containing such marker sequences for rheumatoid arthritis, in particular a protein biochip and the use thereof.
    Type: Application
    Filed: November 3, 2014
    Publication date: March 26, 2015
    Inventors: Jens Beator, Angelika Lüking, Axel Kowald, Helmut E. Meyer
  • Publication number: 20150024962
    Abstract: The present invention relates to new marker sequences for multiple sclerosis and the diagnostic use thereof together with a method for screening of potential active substances for multiple sclerosis by means of these marker sequences. Furthermore, the invention relates to a diagnostic device containing such marker sequences for multiple sclerosis, in particular a protein biochip and the use thereof.
    Type: Application
    Filed: August 6, 2014
    Publication date: January 22, 2015
    Inventors: Jens Beator, Angelika Lüking, Axel Kowald, Helmut Meyer
  • Publication number: 20140371095
    Abstract: The present invention relates to a novel method for identifying specific marker sequences for diagnosis of prostate cancer and/or for prognosis in prostate cancer, and to the use of the specific marker sequences identified with the aid of this method.
    Type: Application
    Filed: November 14, 2012
    Publication date: December 18, 2014
    Applicant: Protagen AG
    Inventors: Peter Amersdorfer, Angelika Lueking, Axel Kowald, Bettina Schlick, Petra Massoner, Christof Seifart, Georg Schäfer, Helmut Klocker, Peter Schulz-Knappe, Klaus Marquart
  • Publication number: 20140371098
    Abstract: The present invention relates to a method for identifying marker sequences for breast cancer, the marker sequences identified with the aid of this method and diagnostic use thereof, diagnostic devices containing marker sequences for breast cancer, in particular an arrangement and a protein array, and use thereof. The invention also relates to method for the screening of potential active agents for the treatment and prevention of breast cancer by means of these marker sequences.
    Type: Application
    Filed: December 24, 2012
    Publication date: December 18, 2014
    Applicant: Protagen AG
    Inventors: Angelika Lüking, Axel Kowald, Annabel Höpner, Christian Scheer, Heidelinde Fiegl, Günter Daxenbichler
  • Publication number: 20140179557
    Abstract: The present invention relates to novel marker sequences for prostate carcinoma while excluding inflammatory prostate diseases or diabetes or polymorbidity and relates to their diagnostic use including a method for screening potential active substances for such prostate diseases by means of these marker sequences. The invention furthermore relates to a diagnostic device including such marker sequences for prostate carcinoma, in particular a protein biochip and its use.
    Type: Application
    Filed: February 24, 2014
    Publication date: June 26, 2014
    Applicant: PROTAGEN AKTIENGESELLSCHAFT
    Inventors: ANGELIKA LUEKING, AXEL KOWALD, HELMUT KLOCKER
  • Publication number: 20140018245
    Abstract: The invention relates to novel marker sequences for multiple sclerosis and to the use thereof in diagnosis as well as to a method for screening potential active ingredients for multiple sclerosis diseases using said marker sequences. The invention further relates to a diagnostic device containing such marker sequences for multiple sclerosis, especially to a protein biochip and the use thereof.
    Type: Application
    Filed: October 12, 2011
    Publication date: January 16, 2014
    Applicant: PROTAGEN Aktiengesellschaft
    Inventors: Angelika Lueking, Axel Kowald, Heike Göhler
  • Publication number: 20130303395
    Abstract: The invention relates to novel marker sequences for systemic lupus erythematosus and to the use thereof in diagnosis as well as to a method for screening potential active ingredients for systemic lupus erythematosus diseases using said marker sequences. The invention further relates to a diagnostic device containing such marker sequences for systemic lupus erythematosus, especially to a protein biochip and the use thereof.
    Type: Application
    Filed: October 12, 2011
    Publication date: November 14, 2013
    Applicant: PROTAGEN AKTIENGESELLSCHAFT
    Inventors: Angelika Lueking, Axel Kowald, Stefan Müllner, Christian Scheer, Matthias Schneider
  • Publication number: 20130244897
    Abstract: The invention relates to novel marker sequences for multiple sclerosis and to the use thereof in diagnosis as well as to a method for screening potential active ingredients for multiple sclerosis diseases the marker sequences. The invention further relates to a diagnostic device containing such marker sequences for multiple sclerosis, especially to a protein biochip and the use thereof.
    Type: Application
    Filed: October 4, 2011
    Publication date: September 19, 2013
    Applicant: Protagen AG
    Inventors: Angelika Lueking, Axel Kowald, Heike Göhler
  • Publication number: 20130217591
    Abstract: The present invention relates to novel marker sequences for inflammatory prostate diseases, prostate carcinoma and the diagnostic use thereof together with a method for screening of potential active substances for inflammatory prostate diseases, prostate carcinoma by means of these marker sequences. Furthermore, the invention relates to a diagnostic device containing such marker sequences for inflammatory prostate diseases, prostate carcinoma, in particular a protein biochip and the use thereof.
    Type: Application
    Filed: April 10, 2013
    Publication date: August 22, 2013
    Applicant: PROTAGEN AKTIENGESELLSCHAFT
    Inventors: HELMUT E. MEYER, ANGELIKA LUEKING, JENS BEATOR, AXEL KOWALD, GEORG BARTSCH, HELMUT KLOCKER
  • Publication number: 20110275528
    Abstract: The present invention relates to novel marker sequences for inflammatory prostate diseases, prostate carcinoma and the diagnostic use thereof together with a method for screening of potential active substances for inflammatory prostate diseases, prostate carcinoma by means of these marker sequences. Furthermore, the invention relates to a diagnostic device containing such marker sequences for inflammatory prostate diseases, prostate carcinoma, in particular a protein biochip and the use thereof.
    Type: Application
    Filed: July 6, 2009
    Publication date: November 10, 2011
    Applicant: PROTAGEN Aktiengesellschaft
    Inventors: Helmut E. Meyer, Angelika Leukling, Jens Beator, Axel Kowald, Georg Bartsch, Helmut Klocker
  • Publication number: 20110184375
    Abstract: The present invention relates to new marker sequences for neurodegenerative diseases and the diagnostic use thereof together with a method for screening of potential active substances for neurodegenerative diseases by means of these marker sequences. Furthermore, the invention relates to a diagnostic device containing such marker sequences for neurodegenerative diseases, in particular a protein biochip and the use thereof.
    Type: Application
    Filed: December 22, 2008
    Publication date: July 28, 2011
    Applicant: Protagen Aktiengesellschaft
    Inventors: Heike Göhler, Helmut E. Meyer, Katrin Marcus, Axel Kowald, Florian Tribl, Manfred Gerlach, Peter Riederer, Angelika Lüking, Christian Scheer, Jens Beator
  • Publication number: 20100280224
    Abstract: The present invention relates to new marker sequences for multiple sclerosis and the diagnostic use thereof together with a method for screening of potential active substances for multiple sclerosis by means of these marker sequences. Furthermore, the invention relates to a diagnostic device containing such marker sequences for multiple sclerosis, in particular a protein biochip and the use thereof.
    Type: Application
    Filed: September 3, 2008
    Publication date: November 4, 2010
    Applicant: Protagen AG
    Inventors: Jens Beator, Angelika Lüking, Axel Kowald, Helmut Meyer
  • Publication number: 20100261881
    Abstract: The present invention relates to new marker sequences for rheumatoid arthritis and the diagnostic use thereof together with a method for screening of potential active substances for rheumatoid arthritis by means of these marker sequences. Furthermore, the invention relates to a diagnostic device containing such marker sequences for rheumatoid arthritis, in particular a protein biochip and the use thereof.
    Type: Application
    Filed: September 3, 2008
    Publication date: October 14, 2010
    Applicant: Protagen AG
    Inventors: Jens Beator, Angelika Lüking, Axel Kowald, Helmut E. Meyer